Please login to the form below

Not currently logged in
Email:
Password:

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

emotive Dr Gill Boucheremotive has appointed Dr Gill Boucher as its new medical director in a role that also sees her join the London-based agency’s senior leadership team.

Dr Boucher arrives at emotive from QuintilesIMS, where she spent seven years, most recently working as product and strategy director developing medical communications.

A qualified physician, she began her career in the NHS before taking up a position with Martindale Pharmaceuticals, where she worked in medical affairs.

Chris Edmonds, emotive’s managing director, said: “Gill is a superb addition to emotive. and strengthens an extremely high calibre senior leadership team with backgrounds from HCP, agency and client-side.

“As emotive completes its transition to a fully fledged international healthcare communications agency with a strong heritage in leveraging technologies to stimulate engagement, Gill’s experience as a practicing physician and in various roles leading teams of medical directors and writers will ensure the agency continues to deliver high-quality scientific communications.“

In her new role at emotive Dr Boucher will oversee the agency’s in-house team of medical writers and provide senior strategic direction in all disciplines of medical communications.

9th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

We are GCI Health, one of the world’s largest specialist health and medical communications agencies with global hubs in London...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics